LAG3 and neoplasm: Furthermore, consistent with the synergistic effect in T cell autoimmunity induced by combined deficiency of PD-1 and LAG-3, combined blockade of PD-1 and LAG-3 in the lymphocytic choriomeningitis virus (LCMV) chronic infection model or in tumor models has a greater therapeutic benefit than blockade of each coinhibitory receptor alone.